Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
25 c » 2 c (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
25 c » 2 c (Expand Search)
-
261
-
262
-
263
Resveratrol decreased intracellular levels of R5P.
Published 2013“…<p>R5P is a pentose phosphate pathway intermediate, an important marker for anabolism (nucleotide biosynthesis). …”
-
264
-
265
-
266
-
267
-
268
-
269
Decreased cardiomyocyte proliferation in <i>Nkx2.5-Cre/Foxm1<sup>fl/fl</sup></i> hearts.
Published 2013“…<p>Microtome sections of paraffin-embedded hearts were prepared from <i>Nkx2.5-Cre/Foxm1<sup>fl/fl</sup></i> and control mice at E14.5 (A–D, J–K), E17.5 (E–F) and P11 (G–H) and stained for proliferation markers phospho-histone 3 (PH3) (A–B, E–H, J–K) and Ki-67 (C–D). …”
-
270
-
271
-
272
-
273
-
274
Fasting-induced decreases of lipogenic gene expression are unimpaired in Bcl6 KO mice.
Published 2014“…Measurements are expressed as the mean+SE for n = fed: 9 WT, 5 KO, fasted: 5 WT, and 3 KO mice. …”
-
275
-
276
-
277
Anti-TGFβ antibody decreased osteoclast numbers and <i>in vitro</i> osteoclastogenesis.
Published 2013“…<p><b>Panel a:</b> Boxplot of number of TRAP positive osteoclasts per millimeter of bone surface in MBA-MB-231 tumor-bearing tibiae, showing significantly decreased osteoclasts upon 1D11 treatment, compared to 13C4. …”
-
278
-
279
-
280
Anti-TGFβ antibody treatment decreases tumor burden in tumor-bearing mice.
Published 2013“…<p><b>Panel a:</b> Representative H&E sections (5×) of tibia from tumor-bearing mice treated with control antibody (13C4) or anti-TGFβ antibody (1D11). …”